Literature DB >> 9809515

Estradiol protects against ischemic injury.

D B Dubal1, M L Kashon, L C Pettigrew, J M Ren, S P Finklestein, S W Rau, P M Wise.   

Abstract

Clinical studies demonstrate that estrogen replacement therapy in postmenopausal women may enhance cognitive function and reduce neurodegeneration associated with Alzheimer's disease and stroke. This study assesses whether physiologic levels of estradiol prevent brain injury in an in vivo model of permanent focal ischemia. Sprague-Dawley rats were ovariectomized; they then were implanted, immediately or at the onset of ischemia, with capsules that produced physiologically low or physiologically high 17beta-estradiol levels in serum (10 or 60 pg/mL, respectively). One week after ovariectomy, ischemia was induced. Estradiol pretreatment significantly reduced overall infarct volume compared with oil-pretreated controls (mean+/-SD: oil = 241+/-88; low = 139+/-91; high = 132+/-88 mm3); this protective effect was regionally specific to the cortex, since no protection was observed in the striatum. Baseline and ischemic regional CBF did not differ between oil and estradiol pretreated rats, as measured by laser Doppler flowmetry. Acute estradiol treatment did not protect against ischemic injury. Our finding that estradiol pretreatment reduces injury demonstrates that physiologic levels of estradiol can protect against neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9809515     DOI: 10.1097/00004647-199811000-00012

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  142 in total

1.  The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties.

Authors:  B Moosmann; C Behl
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Glutamate receptor requirement for neuronal death from anoxia-reoxygenation: an in Vitro model for assessment of the neuroprotective effects of estrogens.

Authors:  L L Zaulyanov; P S Green; J W Simpkins
Journal:  Cell Mol Neurobiol       Date:  1999-12       Impact factor: 5.046

Review 3.  Estrogen neuroprotection and the critical period hypothesis.

Authors:  Erin Scott; Quan-guang Zhang; Ruimin Wang; Ratna Vadlamudi; Darrell Brann
Journal:  Front Neuroendocrinol       Date:  2011-11-04       Impact factor: 8.606

4.  The effects of estrogens on learning in rats with chronic brain cholinergic deficiency in a Morris water test. Identification of the "passive swimming" component.

Authors:  T V Mukhina; N N Lermontova; G I Van'kin; M Oettel; V K P'chev; S O Bachurin
Journal:  Neurosci Behav Physiol       Date:  2004-03

5.  17beta-estradiol protects male mice from cuprizone-induced demyelination and oligodendrocyte loss.

Authors:  Lorelei C Taylor; Kasturi Puranam; Wendy Gilmore; Jenny P-Y Ting; Glenn K Matsushima
Journal:  Neurobiol Dis       Date:  2010-03-27       Impact factor: 5.996

Review 6.  Revisiting the timing hypothesis: biomarkers that define the therapeutic window of estrogen for stroke.

Authors:  Farida Sohrabji; Amutha Selvamani; Robyn Balden
Journal:  Horm Behav       Date:  2012-06-19       Impact factor: 3.587

Review 7.  Neuroprotective action of acute estrogens: animal models of brain ischemia and clinical implications.

Authors:  Tomoko Inagaki; Anne M Etgen
Journal:  Steroids       Date:  2013-02-04       Impact factor: 2.668

8.  Substrain differences, gender, and age of spontaneously hypertensive rats critically determine infarct size produced by distal middle cerebral artery occlusion.

Authors:  Hitonori Takaba; Kenji Fukuda; Hiroshi Yao
Journal:  Cell Mol Neurobiol       Date:  2004-10       Impact factor: 5.046

Review 9.  Sex differences in cognitive impairment and Alzheimer's disease.

Authors:  Rena Li; Meharvan Singh
Journal:  Front Neuroendocrinol       Date:  2014-01-13       Impact factor: 8.606

10.  Selective estrogen receptor modulators (SERMs) enhance neurogenesis and spine density following focal cerebral ischemia.

Authors:  Mohammad M Khan; Chandramohan Wakade; Liesl de Sevilla; Darrell W Brann
Journal:  J Steroid Biochem Mol Biol       Date:  2014-05-09       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.